Germline editing in humans work and have been successful – the tech has diffused around the globe
Yelena Biberman Dr. Biberman is an associate professor of political science at Skidmore College, a fellow at West Point’s Modern War Institute, and a nonresident senior fellow at the Atlantic Council’s South Asia Center The Technologies and International Politics of Genetic Warfare STRATEGIC STUDIES QUARTERLY FALL 2021 https://www.airuniversity.af.edu/Portals/10/SSQ/documents/Volume-15_Issue-3/Biberman.pdf
In 2015, CRISPR (clustered regularly interspaced short palindromic repeats) ushered a “huge revolution” in gene editing by “effectively democratiz[ing] the technology so that everyone is using it.”33 It is now allowing researchers to cheaply and quickly change the DNA of almost any organism, including human.34 The CRISPR technique relies on a class of enzymes (called “Cas” for “CRISPR-associated,” Cas9 in particular) that uses a guide RNA molecule to pinpoint its target DNA that then edits the DNA to disrupt genes or to insert desired sequences. Researchers typically need to order only the RNA fragment, as the other components can be bought off the shelf. The total cost of gene editing is as little as $30, and the technique is even taught in middle-school science classes.35 CRISPR’s affordability, availability, and ease of use increase the prospects of its misuse “not only by a malicious actor but also through accident.”36 Technologies such as CRISPR are, as the US intelligence community’s 2016 worldwide threat assessment put it, “almost always dual-use” and “diffuse rapidly around the globe.”37 And research is gradually overcoming its technical limitations. In 2015, the first human embryos were genetically engineered using CRISPR.38 Efficiency was low, some cells were altered while others were not within the same embryo, and “off-target” mutations were observed. However, in just two years, these problems were largely overcome. Scientists repaired a severe disease-causing mutation by successfully editing genes in human embryos. In the ensuing embryos, all cells were mutation-free, and there was no evidence of off-target mutations.39